Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study.

Ma, Alice D; Kessler, Craig M; Al-Mondhiry, Hamid A B; Gut, Robert Z; Cooper, David L

Ma, Alice D; Kessler, Craig M; Al-Mondhiry, Hamid A B; Gut, Robert Z; Cooper, David L.

Affiliation

Ma AD; aDivision of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina bGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia cDivision of Hematology-Oncology, Penn State Milton S. Hershey Medical Center and Penn State College of Medicine, Hershey, Pennsylvania dClinical, Medical and Regulatory Affairs, Novo Nordisk Inc., Plainsboro, New Jersey, USA.

Blood Coagul Fibrinolysis ; 27(7): 753-760, 2016 Oct.

Article in En | MEDLINE | ID: mdl-26761583

Subject(s)

Factor VIIa/therapeutic use; Hemostasis/genetics; Thrombosis/genetics; Adolescent; Adult; Aged; Aged, 80 and over; Female; Hemophilia A; Humans; Male; Middle Aged; Registries; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Factor VIIa / Hemostasis Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Coagul Fibrinolysis Journal subject: ANGIOLOGIA / HEMATOLOGIA Year: 2016 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google